Latest R&D and Business News
19 April 2024
FDA Approves Genentech’s Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer19 April 2024
Chugai In-Licenses RNAi Therapeutic Zilebesiran for Hypertension with High Cardiovascular RiskNewsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe2023 Sales of Antibodies & Proteins
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports